ArticleTranslational cancer research2021
Aspirin inhibits proliferation and metastasis of canine mammary gland tumor cells through Wnt signaling axis.
Article in Translational cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 4 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast cancer is one of the most common, lethal types of neoplasia. The high mortality is largely due to rapid growth and distal metastasis. Epithelial-mesenchymal transition (EMT) and increased activity of matrix metalloproteinases (MMPs), which are related to tumor aggressiveness and progression, are known to be essential processes. Aspirin, a classic anti-inflammatory treatment, has been shown to inhibit the different types of cancer, though its research have yet to be elucidated and remain controversial.
methodsWe set out to elucidate the mechanism of Aspirin against the metastasis of canine mammary gland tumor cells (CMGTs), and provide theoretical support for the rational use of non-steroidal anti-inflammatory drugs. Firstly, we utilized CCK8, wound healing and transwell invasion assays to determine the effect of Aspirin on proliferation and migration of CMGTs. Next, we determined the effect of Aspirin on Wnt/β-catenin signaling by cellular immunofluorescence and western blot analysis. Finally, Wnt/β-catenin pathway activating agent (Wnt3a) and inhibitor (FH535) were utilized to further validate the relationship between Aspirin and Wnt/β-catenin signaling.
resultsThe results indicated that Aspirin inhibits proliferation and migration of CMGTs in a time-and concentration-dependent manner. Moreover, the inhibitory effect of Aspirin on CMGTs was reduced upon addition of a Wnt pathway activating agent (Wnt3a), while the effect following the addition of Wnt pathway inhibitor (FH535) remained the same as that of Aspirin.
conclusionsOur study demonstrates that Aspirin can inhibit the proliferation, migration and invasion by inhibiting Wnt/β-catenin signaling, which suggest it can be a promising tool for deterring metastasis of CMGTs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.